Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis-Reference-Cited by-同舟云学术

Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis

Published:2021-04 Issue:2 Volume:3 Page:100217
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Shepherd Emma L.,Saborano Raquel,Northall Ellie,Matsuda Kae,Ogino Hitomi,Yashiro Hiroaki,Pickens Jason,Feaver Ryan E.,Cole Banumathi K.,Hoang Stephen A.,Lawson Mark J.,Olson Matthew,Figler Robert A.,Reardon John E.,Nishigaki Nobuhiro,Wamhoff Brian R.,Günther Ulrich L.,Hirschfield Gideon,Erion Derek M.,Lalor Patricia F.

Funder

Takeda Pharmaceutical Company

European Commission

National Institute for Health Research

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference56 articles.

1. A concise review of non-alcoholic fatty liver disease;Than;Atherosclerosis,2015

2. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials;Chiu;Eur J Clin Nutr,2014

3. Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis;Wu;Sci Rep,2016